The recent letter to Pfizer over its Facebook ads for a cancer drug has drawn attention from industry stakeholders. Social media advertising remains a regulatory gray area for pharma brands because ...
Pfizer is timing its Every Inch Matters activation with the 2026 NFL Draft to extend its broader Every Breakthrough Matters cancer screening platform into one of the year’s biggest live sports moments ...
Nearly 140,000 people filed claims against the company for the harm they said its drugs caused. Fewer than half of them will ...
Over the past decade, real estate investment trusts have bought thousands of buildings that house nursing homes, hospitals, ...
Demand today is shaped long before any clinical interaction, with influencers across both HCP and consumer ecosystems playing a central role in driving awareness, trust and action. Cash pay care is ...
MM+M was awarded Best Single Issue of a Tabloid/Newspaper/Magazine for a brand with revenue between $3 million and $7 million ...
The FDA has quietly proposed legislation that would give it more authority to deem drugs misbranded in pharma DTC ads. But ...
Deals: Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, including $3.25 billion ...
Nearly four years after doctors declared Marielle Santos McLeod free of colon cancer, she has yet to feel liberated from the burden of medical expenses. McLeod, who lives near Charleston, South ...
In the most recent Untitled Letter, regulators said language around “fast and lasting responses,” organ-level benefits and ...
The industry-wide debate about how pervasive and deep-seeded vaccine skepticism is in America got an unexpected jolt last week. A poll conducted by Public First on behalf of Politico found that 46% of ...
It follows the appointment of a new chief people officer, Mark Taylor, former chief people adviser at Lego Brand Group.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results